Piggybacking and IOL is a successful technique

Article

Piggybacking with the Add-On IOL is safe, efficient and reliable for correcting pseudophakic refractive errors.

Piggybacking with the Add-On IOL is safe, efficient and reliable for correcting pseudophakic refractive errors.

A team led by Dr B. Basarir, Beyoglu Eye Education and Research Hospital, Istanbul, Turkey, included 10 eyes of 10 patients with pseudophakic refractive errors. All patients were targeted to achieve a range of refraction between -0.50 to +0.50 D.

Preoperative and postoperative outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), endothelial cell count (ECC), anterior chamber depth (ACD), the distance between intraocular lenses and contrast sensitivity measurements under mesopic, scotopic, and scotopic with glare conditions.

The mean preoperative and postoperative UDVA was 0.133±0.12 and 0.73±0.27, respectively. Mean preoperative and postoperative CDVA were 0.77±0.26 and 0.79±0.27, respectively.

The findings revealed the mean preoperative and postoperative ACD to be 3.87±0.91 mm vs. 3.58±1.05 mm, respectively. All patients achieved the target refractive range of -0.50 D to +0.50 D and no complications were recorded.

The abstract, recently published in the European Journal of Ophthalmology can be found here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.